NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy
- PMID: 23594678
- DOI: 10.1038/ki.2013.113
NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy
Abstract
An increasing number of clinical and animal model studies indicate that activation of the innate immune system and inflammatory mechanisms are important in the pathogenesis of diabetic nephropathy. Nucleotide-binding oligomerization domain containing 2 (NOD2), a member of the NOD-like receptor family, plays an important role in innate immune response. Here we explore the contribution of NOD2 to the pathogenesis of diabetic nephropathy and found that it was upregulated in kidney biopsies from diabetic patients and high-fat diet/streptozotocin-induced diabetic mice. Further, NOD2 deficiency ameliorated renal injury in diabetic mice. In vitro, NOD2 induced proinflammatory response and impaired insulin signaling and insulin-induced glucose uptake in podocytes. Moreover, podocytes treated with high glucose, advanced glycation end-products, tumor necrosis factor-α, or transforming growth factor-β (common detrimental factors in diabetic nephropathy) significantly increased NOD2 expression. NOD2 knockout diabetic mice were protected from the hyperglycemia-induced reduction in nephrin expression. Further, knockdown of NOD2 expression attenuated high glucose-induced nephrin downregulation in vitro, supporting an essential role of NOD2 in mediating hyperglycemia-induced podocyte dysfunction. Thus, NOD2 is one of the critical components of a signal transduction pathway that links renal injury to inflammation and podocyte insulin resistance in diabetic nephropathy.
Comment in
-
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner.Kidney Int. 2013 Aug;84(2):225-8. doi: 10.1038/ki.2013.122. Kidney Int. 2013. PMID: 23903414
Similar articles
-
Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.Int J Clin Exp Pathol. 2014 Jan 15;7(2):481-95. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24551269 Free PMC article.
-
Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.Kidney Int. 2014 Oct;86(4):712-25. doi: 10.1038/ki.2014.111. Epub 2014 Apr 9. Kidney Int. 2014. PMID: 24717296
-
Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.Metabolism. 2017 Nov;76:56-69. doi: 10.1016/j.metabol.2017.07.009. Epub 2017 Aug 8. Metabolism. 2017. PMID: 28987240 Free PMC article.
-
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.Nephrology (Carlton). 2018 Oct;23 Suppl 4:32-37. doi: 10.1111/nep.13451. Nephrology (Carlton). 2018. PMID: 30298646 Review.
-
Wnt signaling and podocyte dysfunction in diabetic nephropathy.J Investig Med. 2017 Dec;65(8):1093-1101. doi: 10.1136/jim-2017-000456. Epub 2017 Sep 20. J Investig Med. 2017. PMID: 28935636 Review.
Cited by
-
The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury.Kidney Dis (Basel). 2016 Apr;2(1):28-36. doi: 10.1159/000444736. Epub 2016 Mar 8. Kidney Dis (Basel). 2016. PMID: 27536689 Free PMC article. Review.
-
Role of Podocyte Injury in Glomerulosclerosis.Adv Exp Med Biol. 2019;1165:195-232. doi: 10.1007/978-981-13-8871-2_10. Adv Exp Med Biol. 2019. PMID: 31399967 Free PMC article. Review.
-
Histone demethylase UTX is a therapeutic target for diabetic kidney disease.J Physiol. 2019 Mar;597(6):1643-1660. doi: 10.1113/JP277367. Epub 2018 Dec 25. J Physiol. 2019. PMID: 30516825 Free PMC article.
-
CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.Clin Exp Immunol. 2023 Mar 24;211(3):224-232. doi: 10.1093/cei/uxad002. Clin Exp Immunol. 2023. PMID: 36622793 Free PMC article.
-
Role and molecular mechanism of NOD2 in chronic non-communicable diseases.J Mol Med (Berl). 2024 Jun;102(6):787-799. doi: 10.1007/s00109-024-02451-7. Epub 2024 May 14. J Mol Med (Berl). 2024. PMID: 38740600 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical